Sun Yat-sen University Cancer Center

This study is testing whether adding a drug called bevacizumab to a precise form of radiation therapy works better for controlling lung cancer that has spread to the brain. It will compare three different treatment approaches in 258 patients. The main goal is to see if the combin…

This study is testing if adding the antibiotic moxifloxacin to standard first-line chemotherapy helps people with metastatic triple-negative breast cancer live longer without their cancer getting worse. It will involve about 228 participants across multiple centers. Patients will…